Segmented pre-formed intrastromal corneal insert

• US 5,824,086 A
• Filed: 09/20/1996
• Issued: 10/20/1998
• Est. Priority Date: 08/02/1993
• Status: Expired due to Term

• Current Assignee: Addition Technology, Inc. (AJL Ophthalmic SA)
• Original Assignee: KeraVision, Inc.
• Inventors: Silvestrini, Thomas A.
• Primary Examiner(s): SHAY, RANDY CITRIN
• Application Number:
  US08/718,291
• Time in Patent Office: 760 Days
• Field of Search: 623/4, 623/5, 606/107
• US Class Current: 623/5.11
• CPC Class Codes: A61F 2/147 Implants to be inserted in the stroma for refractive correction, e.g. ring-like implants
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts

Abstract

This invention is a pre-formed intrastromal corneal insert. It is made of a physiologically compatible polymer and may be used to adjust corneal curvature and thereby correct vision abnormalities. The insert or segment may also be used to deliver therapeutic or diagnostic agents to the interior of the cornea or of the eye. The insert subtends only a portion of a ring, or "arc", encircling the anterior cornea outside of the cornea'"'"'s field of view. The invention also includes a procedure for inserting the device into the cornea.

Claims

1. An intracorneal insert for introduction into the cornea of a human eye, said insert comprising an arcuate, physiologically compatible synthetic, polymeric segment having a predetermined shape prior to implantation in the cornea, said segment subtending an arc substantially less than 360°

and being adapted for implantation within a human cornea and configured for altering the shape of the cornea by substantially a predetermined amount, said segment being constructed to substantially retain said predetermined shape over time after implantation in the cornea.

2. The insert of claim 1 wherein the segment subtends an arc less than about 320°

.

3. The insert of claim 2 wherein the segment subtends an arc less than about 270°

.

4. The insert of claim 3 wherein the segment subtends an arc of 20°

to 90°

.

5. The insert of claim 2 wherein the segment comprises a physiologically compatible polymer having a low modulus of elasticity.

6. The insert of claim 5 wherein the low modulus physiologically compatible polymer is selected from the group consisting of polyhydroxyethylmethylacrylate (Poly-HEMA), polyvinylpyrrolidone (PVP), polyethylene oxide, polyacrylates, polyacrylic acid and its derivatives, their copolymers and interpolymers, silicones, crosslinked dextran, crosslinked heparin, and hyaluronic acid.

7. The insert of claim 6 wherein the low modulus physiologically compatible polymer is selected from polyhydroxyethylmethylacrylate (Poly-HEMA) and polyvinylpyrrolidone (PVP).

8. The insert of claim 5 further comprising a drug or biologic agent.

9. The insert of claim 8 wherein the drug or biologic agent is selected from the group consisting of dexamethasone, heparin, corticosteroids, antimitotics, antifibrotics, antiinflammatory, anti-scar-forming, anti-adhesion, antithrombogenic, and antiangiogenesis factors.

10. The insert of claim 9 where the drug or biologic agent comprises an antiinflammatory or antithrombogenic.

11. The insert of claim 2 wherein the segment comprises a polymer having a high modulus of elasticity.

12. The insert of claim 11 wherein the polymer having a high modulus of elasticity is one or more members selected from the group consisting of PMMA, polytetrafluoroethylene, polysulfones, polycarbonate, epoxies, a polyolefin selected from polyethylene, polypropylene, polybutylene, mixtures, and interpolymers.

13. The insert of claim 12 where the polymer having a high modulus of elasticity comprises PMMA.

14. The insert of claim 1 wherein the segment has a cavity formed therein.

15. The insert of claim 14 further comprising a drug or biologic agent disposed in said cavity.

16. The insert of claim 15 wherein the drug or biologic agent is selected from dexamethasone, heparin, corticosteroids, antimitotics, antifibrotics, antiinflammatories, anti-scar-forming, anti-adhesion, antithrombogenic, and antiangiogenesis factors.

17. The insert of claim 16 wherein the drug or biologic agent comprises an antiinflammatory or antithrombogenic.

18. The insert of claim 1 further comprising an ocular lubricant.

19. The insert of claim 18 wherein the ocular lubricant is selected from the group consisting of hyaluronic acid, methylethylcellulose, dextran solutions glycerine solutions, polysaccharides, and oligosaccharides.

20. The insert of claim 1 further including a coupling member coupled to said segment coupling the insert to another one of said segments.

21. The insert of claim 1 in combination with another one of said segments, said segments being coupled to one another to form an assemblage.

22. The insert of claim 21 wherein the shape of one segment differs from that of the other.

23. The insert of claim 21 wherein said segments have similar thicknesses.

24. The insert of claim 1 wherein said segment comprises at least two polymeric layers.

25. The insert of claim 24 where at least one of said polymeric layers comprises a low modulus physiologically compatible polymer.

26. The insert of claim 25 where at least one of said polymeric layers comprises a high modulus physiologically compatible polymer.

27. The insert of claim 1 wherein said segment includes a channel formed therein.

28. The insert of claim 27 further including a member extending through said channel and extending from said segment.

29. The insert of claim 1 wherein said segment comprises multiple sections.

30. The insert of claim 29 wherein said sections are nested.

31. The insert of claim 1 wherein said segment is configured and adapted for implantation within a human cornea for altering the shape of the cornea by substantially a predetermined amount when positioned completely below the anterior surface of the cornea.

32. An intracorneal insert for introduction into the cornea of a human eye, said insert comprising an arcuate, physiologically compatible synthetic, polymeric segment having a predetermined shape prior to implantation in the cornea, said segment subtending an arc substantially less than 360°

and being adapted for implantation within a human cornea and configured to alter the topography of the cornea in a manner that effects correction of a predetermined refractive disorder of the eye, said segment being constructed to substantially retain said shape over time after implantation within the cornea.

33. The insert of claim 32 wherein the segment subtends an arc less than about 320°

.

34. The insert of claim 33 wherein the segment subtends an arc less than about 270°

.

35. The insert of claim 34 wherein the segment subtends an arc of 20°

to 90°

.

36. The insert of claim 33 wherein the segment comprises a physiologically compatible polymer having a low modulus of elasticity.

37. The insert of claim 36 wherein the low modulus physiologically compatible polymer is selected from the group consisting of polyhydroxyethylmethylacrylate (Poly-HEMA), polyvinylpyrrolidone (PVP), polyethylene oxide, polyacrylates, polyacrylic acid and its derivatives, their copolymers and interpolymers, silicones, crosslinked dextram, crosslinked heparin, and hyaluronic acid.

38. The insert of claim 37 wherein the low modulus physiologically compatible polymer is selected from polyhydroxyethylmethylacrylate (Poly-HEMA) and polyvinylpyrrolidone (PVP).

39. The insert of claim 36 further comprising a drug or biologic agent.

40. The insert of claim 39 wherein the drug or biologic agent is selected from the group consisting of dexamethasone, heparin, corticosteroids, antimitotics, antifibrotics, antiinflammatory, anti-scar-forming, anti-adhesion, antithrombogenic, and antiangiogenesis factors.

41. The insert of claim 40 wherein the drug or biologic agent comprises an antiinflammatory or antithrombogenic.

42. The insert of claim 33 wherein the segment comprises a polymer having a high modulus of elasticity.

43. The insert of claim 42 wherein the polymer having a high modulus of elasticity is one or more members selected from the group consisting of PMMA, polytetrafluroethylene, polysulfones, polycarbonate, epoxies, a polyolefin selected from polyethylene, polypropylene, polybutylene, mixtures, and interpolymers.

44. The insert of claim 43 wherein the polymer having a high modulus of elasticity comprises PMMA.

45. The insert of claim 32 additionally comprising an ocular lubricant.

46. The insert of claim 45 wherein the ocular lubricant comprises a material selected from the group consisting of hyaluronic acid, methylethylcellulose, dextran solutions, glycerine solutions, polysaccharides, and oligosaccharides.

47. The insert of claim 32 further including a coupling member coupled to said segment for coupling the insert to another one of said segments.

48. The insert of claim 32 in combination with another one of said segments, said segments being coupled to one another to form an assemblage.

49. The insert of claim 32 wherein said segment is configured and adapted for implantation within a human cornea for altering the topography of the cornea in a manner that effects correction of a predetermined refractive disorder of the eye when positioned completely below the anterior surface of the cornea.

50. An assemblage for introduction into the cornea of a human eye, said assemblage comprising multiple physiologically compatible, arcuate segments, each having a predetermined shape, each subtending an arc less than 360°

and being adapted for implantation within a human cornea and configured for altering the shape of the cornea by substantially a predetermined amount, each segment being constructed to substantially retain said predetermined shape over time after implantation in the cornea and each segment being coupled to another one of said segments.

51. The assemblage of claim 50 wherein said segments are arranged to form portions of a ring and have a combined arc length less than 360°

.

52. The assemblage of claim 51 wherein said segments are arranged in a plane.

53. The assemblage of claim 51 wherein said segments are spaced from one another.

54. The assemblage of claim 50 wherein at least one segment includes overlapping sections.